Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
15.30
+0.30 (2.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
Myriad Genetics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Myriad Genetics stock have an average target of 26.64, with a low estimate of 20 and a high estimate of 35. The average target predicts an increase of 74.12% from the current stock price of 15.30.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MYGN stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 3 | 4 | 4 | 4 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 11 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $21 | Hold | Maintains | $32 → $21 | +37.25% | Nov 18, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $24 | Hold | Maintains | $30 → $24 | +56.86% | Nov 11, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $32 | Hold | Initiates | $32 | +109.15% | Sep 19, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $35 | Buy | Initiates | $35 | +128.76% | Aug 27, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $29 → $34 | Buy | Maintains | $29 → $34 | +122.22% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
857.55M
from 753.20M
Increased by 13.85%
Revenue Next Year
923.86M
from 857.55M
Increased by 7.73%
EPS This Year
0.11
from -3.18
EPS Next Year
0.25
from 0.11
Increased by 128.52%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 887.3M | 988.8M | 1.1B | ||
| Avg | 857.6M | 923.9M | 1.0B | ||
| Low | 821.0M | 820.9M | 867.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.8% | 15.3% | 19.2% | ||
| Avg | 13.9% | 7.7% | 9.8% | ||
| Low | 9.0% | -4.3% | -6.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.15 | 0.45 | 0.86 | ||
| Avg | 0.11 | 0.25 | 0.51 | ||
| Low | 0.09 | -0.05 | 0.05 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 308.8% | 241.1% | ||
| Avg | - | 128.5% | 103.0% | ||
| Low | - | - | -80.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.